BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31384958)

  • 1. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Hautarzt; 2019 Sep; 70(9):723-741. PubMed ID: 31384958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scleroderma].
    Distler O; Gay S
    Internist (Berl); 2010 Jan; 51(1):30-8. PubMed ID: 20033389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis.
    Denton CP; Khanna D
    Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic sclerosis : What is currently available for treatment?].
    Becker MO
    Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
    Cepeda EJ; Reveille JD
    Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pathogenesis and treatment of systemic sclerosis.
    Denton CP
    Clin Med (Lond); 2016 Feb; 16(1):55-60. PubMed ID: 26833515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pathogenesis and treatment of systemic sclerosis.
    Denton CP
    Clin Med (Lond); 2015 Dec; 15 Suppl 6():s58-63. PubMed ID: 26634684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis in 2017].
    Soukup T; Veleta T
    Vnitr Lek; 2018; 64(2):146-154. PubMed ID: 29595279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Skin Conditions: Systemic Sclerosis.
    Helm LA; Clebak KT; Foulke G; Helm M
    FP Essent; 2023 Mar; 526():18-24. PubMed ID: 36913659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.
    Mahler M; Hudson M; Bentow C; Roup F; Beretta L; Pilar Simeón C; Guillén-Del-Castillo A; Casas S; Fritzler MJ
    Autoimmun Rev; 2020 Aug; 19(8):102583. PubMed ID: 32553611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis: An update in 2016.
    Desbois AC; Cacoub P
    Autoimmun Rev; 2016 May; 15(5):417-26. PubMed ID: 26802722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine.
    Lescoat A; Bellando-Randone S; Campochiaro C; Del Galdo F; Denton CP; Farrington S; Galetti I; Khanna D; Kuwana M; Truchetet ME; Allanore Y; Matucci-Cerinic M
    Lancet Rheumatol; 2023 Nov; 5(11):e683-e694. PubMed ID: 38251534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.